Evidence map›Paper›PMID 40860001›Full record

ReviewJournal of pharmacy & bioallied sciences

Diabetic Kidney Disease in Type 2 Diabetes: A Comprehensive Review of Epidemiology, Pathophysiology, and Therapeutic Advances.

A Uma, Shanmugapriyan Sivaraman, Rajesh Manoharan, Panneerselvam Periasamy

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of pharmacy & bioallied sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Exploring the Mechanisms ofInternational journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

A UmaDepartment of Pharmacology, Surabhi Institute of Medical Sciences, KNRUHS (Kaloji Narayana Rao University of Health Sciences), Siddipet, Telangana, India.
Shanmugapriyan SivaramanDepartment of Pharmacology, Meenakshi Medical College, Meenakshi Academy of Higher Education and Research (MAHER) (Deemed to be University), Kanchipuram, Tamil Nadu, India.
Rajesh ManoharanDepartment of Pharmacology, Sri Muthukumaran Medical College Hospital and Research Institute, (Affiliated Under The Tamil Nadu Dr. M. G. R. Medical University), Chennai, Tamil Nadu, India.
Panneerselvam PeriasamyDepartment of Physiology, Government Erode Medical College (Affiliated Under The Tamil Nadu Dr. M. G. R. Medical University), Erode, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic kidney disease (CKD) is a major complication of type 2 diabetes mellitus (

Indexed as

Biomarkerschronic kidney diseasehypoglycemic agentsSGLT2 inhibitorstype 2 diabetes mellitus

Identifiers

PMID40860001
PMCPMC12373389

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.